Renalytix plc (RNLX) Share-based Payment Arrangement, Expense USD 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Renalytix plc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2024.
  • Renalytix plc Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $385 K, a 50% decline year-over-year.
  • Renalytix plc Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $1.88 M, a 54.7% decline year-over-year.
  • Renalytix plc annual Share-based Payment Arrangement, Expense for 2023 was $2.94 M, a 36.5% decline from 2022.
  • Renalytix plc annual Share-based Payment Arrangement, Expense for 2022 was $4.62 M, a 78.7% increase from 2021.
  • Renalytix plc annual Share-based Payment Arrangement, Expense for 2021 was $2.59 M, a 123% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.88 M $385 K -$385 K -50% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $2.27 M $385 K -$430 K -52.8% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-14
Q3 2023 $2.7 M $524 K -$239 K -31.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $2.94 M $588 K -$1.22 M -67.5% Apr 1, 2023 Jun 30, 2023 10-K 2023-09-28
Q1 2023 $4.16 M $770 K -$153 K -16.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $4.31 M $815 K -$98 K -10.7% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-14
Q3 2022 $4.41 M $763 K -$211 K -21.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $4.62 M $1.81 M Apr 1, 2022 Jun 30, 2022 10-K 2023-09-28
Q1 2022 $923 K +$922 K +150964% Jan 1, 2022 Mar 31, 2022 6-K 2023-06-09
Q4 2021 $913 K +$411 K +81.9% Oct 1, 2021 Dec 31, 2021 6-K 2023-03-30
Q3 2021 $974 K Jul 1, 2021 Sep 30, 2021 6-K 2022-11-30
Q1 2021 $611* Jan 1, 2021 Mar 31, 2021 6-K 2022-06-30
Q4 2020 $502 K Oct 1, 2020 Dec 31, 2020 6-K/A 2022-04-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.